BCCG Blue Chip Capital Group Inc.
AI brief AI-written, not reviewed by a person
Latest filings show continuing negative stockholders’ equity and declining operating metrics, with 12-month periods ending 2026-05-31 posting -22650614 USD net income and -21739600 USD operating income, while total assets remain small and liabilities remain elevated around 1.7–3.1 million USD in 2026. Cash and equivalents at year-end 2024 and 2023 show modest balances (1403 USD and 1950 USD, respectively), with a larger but still negative equity position appearing in 2026. Shares outstanding have grown to approximately 109,090,037 as of 2026-10-13, indicating substantial share count versus earlier periods.
- 12 months to 2026-05-31: -22650614 USD net income, and 12 months to 2025-05-31: -5693136 USD net income. [1]
- 12 months to 2026-05-31: -21739600 USD operating income, and 12 months to 2025-05-31: -5620970 USD operating income. [1]
- Total liabilities at 2026-08-31: 1741131 USD, at 2026-05-31: 3139121 USD, at 2026-02-28: 1800272 USD. [1]
- Total assets at 2026-08-31: 120564 USD, at 2026-05-31: 88590 USD, at 2026-02-28: 88590 USD. [1]
- Stockholders’ equity at 2026-08-31: -1620567 USD, at 2026-05-31: -3050531 USD. [1]
- Shares outstanding at 2026-10-13: 109090037 shares. [1]
- Cash and equivalents: 1403 USD at 2024-02-29, 1950 USD at 2023-11-30, and 1758 USD at 2023-05-31. [1]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
What the sources did not support
- No explicit revenue figures were provided to contextualize operating losses.
- No per-share amount for net income or EPS is given beyond the Diluted EPS (year) figures, which are provided but not reconciled.
- Observed periods cover multiple dates; no consolidated date-aligned comparison table supplied beyond individual line items.
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Net income (quarter) (3 months to 2026-08-31) | -899,933 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2026-05-31) | -22,650,614 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-08-31) | -725,376 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2026-05-31) | -21,739,600 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-08-31) | -0.0084 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2026-05-31) | -0.2354 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-08-31) | -718,026 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2026-05-31) | -1,305,393 USD | sec-companyfacts | current | ||
| Total assets (at 2026-08-31) | 120,564 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-08-31) | 1,741,131 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-08-31) | -1,620,567 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2024-02-29) | 1,403 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-13) | 109,090,037 shares | sec-companyfacts | current |
Context
No reviewed context has been published for BCCG. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add BCCG to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: BCCG.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.